HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine given eight weeks apart can elicit immune responses against the human immunodeficiency virus.

from CNN.com - RSS Channel - HP Hero https://ift.tt/uQ0CfLN
via IFTTT